Affinity Asset Advisors »

ProMIS Neurosciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of ProMIS Neurosciences (PMN) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in ProMIS Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including ProMIS Neurosciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ProMIS Neurosciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $527k 266k 1.98

More positions owned by Affinity Asset Advisors

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Apogee Therapeutics (APGE)
Establishment Labs Holdings Ord (ESTA)
Cymabay Therapeutics
Immunovant (IMVT)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Madrigal Pharmaceuticals (MDGL)
Xenon Pharmaceuticals (XENE)
Alkermes SHS Call Option (ALKS)
Kura Oncology (KURA)
Astria Therapeutics (ATXS)
Morphic Hldg (MORF)

View all positions for Affinity Asset Advisors

Top funds holding ProMIS Neurosciences

Sphera Funds Management
Northeast Financial Consultants
Ieq Capital
Hara Capital
Fiduciary Trust Company
Kingsview Wealth Management
CLARET ASSET MANAGEMENT Corp
UBS Group
Bank of America Corporation
Royal Bank of Canada
Jpmorgan Chase & Co
National Bank Of Canada /fi/
AllSquare Wealth Management
TD Waterhouse Canada

View all funds holding ProMIS Neurosciences